ERS International Congress 2022: highlights from the Thoracic Oncology Assembly

por Catarata, Maria Joana, Van Geffen, Wouter H., Banka, Radhika, Ferraz, Beatriz, Sidhu, Calvin, Carew, Alan, Viola, Lucia, Gijtenbeek, Rolof, Hardavella, Georgia
Publicado 2023

Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nat...

por Gijtenbeek, Rolof G.P., Damhuis, Ronald A.M., van der Wekken, Anthonie J., Hendriks, Lizza E.L., Groen, Harry J.M., van Geffen, Wouter H.
Publicado 2023

Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC

por Wei, Jiacong, Meng, Pei, Terpstra, Miente Martijn, van Rijk, Anke, Tamminga, Menno, Scherpen, Frank, ter Elst, Arja, Alimohamed, Mohamed Z., Johansson, Lennart F., Stigt, Jos, Gijtenbeek, Rolof P. G., van Putten, John, Hiltermann, T. Jeroen N., Groen, Harry J. M., Kok, Klaas, van der Wekken, Anthonie J., van den Berg, Anke
Publicado 2021

Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer

por Gijtenbeek, Rolof G.P., van der Noort, Vincent, Aerts, Joachim G.J.V., Staal-van den Brekel, Jeske A., Smit, Egbert F., Krouwels, Frans H., Wilschut, Frank A., Hiltermann, T. Jeroen N., Timens, Wim, Schuuring, Ed, Janssen, Joost D.J., Goosens, Martijn, van den Berg, Paul M., de Langen, A. Joop, Stigt, Jos A., van den Borne, Ben E.E.M., Groen, Harry J.M., van Geffen, Wouter H., van der Wekken, Anthonie J.
Publicado 2022